Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;25(1):63-70.
doi: 10.1089/jwh.2015.5259. Epub 2015 Aug 28.

Risk Factors for Venous Thromboembolism Among Reproductive Age Women

Affiliations

Risk Factors for Venous Thromboembolism Among Reproductive Age Women

Carolyn L Westhoff et al. J Womens Health (Larchmt). 2016 Jan.

Abstract

Background: Venous thromboembolism (VTE) is rare among young women and is often presumed to occur in the setting of a genetic predisposition or during the use of estrogen-containing combined hormonal contraceptive or to have an unknown cause. This study aims to describe the distribution of VTE risk factors among women with a confirmed VTE.

Methods: We identified all women aged 15-46 years with a VTE diagnosis at Columbia University Medical Center from 2005 to 2012 using medical center databases. We then reviewed all electronic medical records to validate the diagnoses and identify risk factors associated with each confirmed case.

Results: We identified 315 cases and confirmed 186 (59%). The proportion of unconfirmed cases increased over time. Forty percent of confirmed cases were associated with hormonal contraceptives or pregnancy. Ninety-five percent of confirmed cases had identifiable major risk factors including a personal history, family history, malignancy or other predisposing illness, recent long-haul travel, trauma, hospitalization, and obesity; many had multiple simultaneous risk factors. None of the confirmed cases was associated with a previously known genetic predisposition, but in 10 confirmed cases a genetic predisposition was identified during evaluation. In only 10 of the 186 confirmed cases could we not identify any acquired risk factor, and only 2 of those 10 women had a genetic predisposition.

Conclusions: Many reproductive age women experiencing a VTE have risk factors unique to this group, and most have multiple risk factors, confirming that this is a multifactorial disease. The large proportion of unconfirmed cases suggests the need for great caution in using administrative databases for research due to poor diagnostic specificity and due to lack of information about additional risk factors.

PubMed Disclaimer

Conflict of interest statement

CLW consults for Merck and Bayer, both of which manufacture hormonal contraceptives. The other authors do not report any competing financial interests.

Figures

<b>FIG. 1.</b>
FIG. 1.
Flow diagram of chart review process. VTE, venous thrombo-embolism; CUMC, Columbia University Medical Center.

Similar articles

Cited by

References

    1. European Society of Human Reproduction and Embryology (ESHRE) Capri Workshop Group. Venous thromboembolism in women: A specific reproductive health risk. Hum Reprod Update 2013;19:471–482 - PubMed
    1. Al-Badri A, Spyropoulos AC. Treatment and long-term management of venous thromboembolism. Clin Lab Med 2014;34:519–536 - PubMed
    1. de Bastos M, Stegeman BH, Rosendaal FR, et al. . Combined oral contraceptives: Venous thrombosis. Cochrane Database Syst Rev 2014;3:CD010813 - PMC - PubMed
    1. van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: Results of the MEGA case-control study. BMJ 2009;339:b2921. - PMC - PubMed
    1. Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 2008;6:632–637 - PubMed

Publication types

Substances

LinkOut - more resources